• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

meplazumab Inhibitor

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS5759576

meplazumab is a humanized anti-CD147 antibody, as add-on therapy in patients with COVID-19 pneumonia. More details

DISCONTINUED
Click here to view our similar product(s) OR click here to contact our technical support team for suitable replacement.
Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Product Name
meplazumab, Inhibitor
Full Product Name
meplazumab
Form/Format
Solid. Powder
Purity/Purification
98.00%
Preparation and Storage
Store at -20 degree C for 3 years powder
-80 degree C for 2 years in solvent
Solubility
<1mg/ml refers to the product slightly soluble or insoluble
Target & IC50
CD147

Product Categories/Family for meplazumab, inhibitor

Product References and Citations for meplazumab, inhibitor

Huijie Bian, Zhao-Hui Zheng, Ding Wei,et al.Meplazumab treats COVID-19 pneumonia: an open-labelled, concurrent controlled add-on clinical trial. BioRxiv.2020.

Other Notes

Small volumes of meplazumab, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for meplazumab purchase

MBS5759576 is an inhibitor targeting meplazumab.
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000